Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01566175 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

Study acronym: Reducer
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv8
  2. Primary completion date: Dec 31, 2028 to Dec 31, 2030
    • Study completion date: Dec 31, 2029 to Dec 31, 2031
    v7
  3. Primary completion date: Dec 31, 2021 to Dec 31, 2028
    • Study completion date: Dec 31, 2022 to Dec 31, 2029
    v6
  4. Primary completion date: Dec 31, 2020 to Dec 31, 2021
    • Study completion date: Dec 31, 2020 to Dec 31, 2022
    v5
  5. Enrollment target: 50 to 100
    • Primary and study completion dates: Dec 2017 to Dec 31, 2020
    • Start date: Aug 2011 to Aug 30, 2011
    • Site details revised at 1 of 2 sites
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Dec 2014 to Dec 2017
    • Study completion date: Dec 2015 to Dec 2017
    • Start date: Apr 2012 to Aug 2011
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to implant the Reducer in patients with the symptoms of refractory angina, that suffer from refractory angina who demonstrate reversible ischemia.
Trial Details
NCT Number NCT01566175
Lead Sponsor Tel-Aviv Sourasky Medical Center
Collaborators: Shockwave Medical, Inc.
Conditions
(from sponsor)		 Refractory Angina
Related terms Angina Pectoris
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov